Effects of Sorafenib on Intra-Tumoral Interstitial Fluid Pressure and Circulating Biomarkers in Patients with Refractory Sarcomas (NCI Protocol 6948).

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request